Multiple Sclerosis Patient Macrophages Impaired Metabolism Leads to an Altered Response to Activation Stimuli

Jennifer Fransson1, Corinne Bachelin1, Farid Ichou1

  • 1From the Sorbonne Université (J.F., C.B., L.G.-N., E.M., A.T., F.M., C.L., V.Z.), Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital Pitié Salpétrière Univ. Hosp., DMU Neuroscience 6; Inst. of Cardiometabolism and Nutrition (F.I., M.P.), Sorbonne-universités-Upmc 06, INSERM, CNRS; Laboratoire des Signaux et Systèmes (L2S) (A.G., A.T.), CNRS-CentraleSupélec, Université Paris-Saclay; Sorbonne Université (B.S.), Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital St. Antoine-HUEP; and INSERM (B.F.), SU, AP-HP, Centre de recherche en Myologie-UMR974 and Service of Neuro-Myology, Institute of Myology, University hospital Pitié-Salpêtriere.

Abstract

Insights

Multiple sclerosis (MS) patient macrophages show defects in myelin processing and promote inflammation. These findings highlight intrinsic macrophage dysfunction in MS and suggest them as potential therapeutic targets.

Area of Science:

  • Neuroimmunology
  • Cellular Biology
  • Metabolomics

Background:

  • Multiple sclerosis (MS) involves immune cell invasion of the central nervous system (CNS), leading to myelin destruction.
  • Macrophages play a dual role in demyelination and myelin repair, influenced by their phenotype.
  • Understanding macrophage dysfunction in MS is crucial for identifying therapeutic strategies.

Purpose of the Study:

  • To investigate potential defects in macrophage responses in MS patients.
  • To determine if these defects contribute to increased inflammation or impaired neuroregeneration in MS.
  • To explore the functional and metabolic profiles of macrophages from MS patients.

Main Methods:

  • Monocytes from MS patients and healthy controls (HCs) were differentiated into macrophages in vitro.
  • RNA sequencing and metabolomics were used to assess macrophage activation profiles.
  • Flow cytometry evaluated surface markers and myelin phagocytosis; supernatant effects on oligodendrocyte precursor cells were tested.

Main Results:

  • MS patient macrophages preferentially adopted a proinflammatory CD16+ phenotype, overrepresented in MS lesions.
  • MS macrophages exhibited reduced myelin phagocytosis and impaired myelin processing.
  • MS macrophage supernatant favored astrocytic differentiation over oligodendroglial differentiation.
  • MS macrophages maintained a proinflammatory transcriptomic profile and showed mitochondrial energy metabolism defects.

Conclusions:

  • MS patient macrophages possess intrinsic defects, suggesting a role for innate immune cell memory in MS.
  • These findings underscore the significance of macrophages as potential therapeutic targets in MS.
  • Defective macrophage function in MS contributes to neuroinflammation and hinders repair mechanisms.